Cite
HARVARD Citation
Lapointe, H. et al. (2023). People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses. Journal of infectious diseases. pp. 838-849. [Online].